Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters

The clinical relevance of gray/white matter contrast ratio (GWR) in mild cognitive impairment (MCI) remains unknown. This study examined baseline GWR and 3-year follow-up diagnostic status in MCI. Alzheimer’s Disease Neuroimaging Initiative MCI participants with baseline 1.5 T MRI and 3-year follow-up clinical data were included. Participants were categorized into two groups based on 3-year follow-up diagnoses: 1) non-converters (n = 69, 75 ± 7, 26 % female), and 2) converters (i.e., dementia at follow-up; n = 69, 75 ± 7, 30 % female) who were matched on baseline age and Mini-Mental State Examination scores. Groups were compared on FreeSurfer generated baseline GWR from structural images in which higher values represent greater tissue contrast. A general linear model, adjusting for APOE-status, scanner type, hippocampal volume, and cortical thickness, revealed that converters evidenced lower GWR values than non-converters (i.e., more degradation in tissue contrast; p = 0.03). Individuals with MCI who convert to dementia have lower baseline GWR values than individuals who remain diagnostically stable over a 3-year period, statistically independent of cortical thickness or hippocampal volume.

[1]  K. Ishii,et al.  Alteration of white matter MR signal intensity in frontotemporal dementia. , 1997, AJNR. American journal of neuroradiology.

[2]  Anders M. Dale,et al.  Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray/white contrast: A multi-sample MRI study , 2009, NeuroImage.

[3]  Nick C Fox,et al.  The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.

[4]  R. Green,et al.  APOE, vascular pathology, and the AD brain , 2005, Neurology.

[5]  et al.,et al.  Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.

[6]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[7]  M. Albert,et al.  Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.

[8]  A. Dale,et al.  Thinning of the cerebral cortex in aging. , 2004, Cerebral cortex.

[9]  M. Murphy,et al.  Postmortem Pittsburgh Compound B (PiB) binding increases with Alzheimer's disease progression. , 2012, Journal of Alzheimer's disease : JAD.

[10]  Anders M. Dale,et al.  Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer , 2006, NeuroImage.

[11]  Orrin Devinsky,et al.  Detection of Epileptogenic Cortical Malformations with Surface-Based MRI Morphometry , 2011, PloS one.

[12]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[13]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[14]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[15]  Li Shen,et al.  Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.

[16]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[17]  Naftali Raz,et al.  Cerebral correlates of cognitive aging: Gray-white-matter differentiation in the medial temporal lobes, and fluid versus crystallized abilities , 1990, Psychobiology.

[18]  E. Halgren,et al.  Individual Differences in Verbal Abilities Associated with Regional Blurring of the Left Gray and White Matter Boundary , 2011, The Journal of Neuroscience.

[19]  J. Baron,et al.  In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.

[20]  Gwenn S. Smith,et al.  Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. , 1991, Radiology.

[21]  A. Dale,et al.  High‐resolution intersubject averaging and a coordinate system for the cortical surface , 1999, Human brain mapping.

[22]  A. Meyer-Lindenberg,et al.  Normal age-related brain morphometric changes: nonuniformity across cortical thickness, surface area and gray matter volume? , 2012, Neurobiology of Aging.

[23]  G. V. Van Hoesen,et al.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.

[24]  Abraham Z. Snyder,et al.  A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume , 2004, NeuroImage.

[25]  S Greenland,et al.  The relative efficiencies of matched and independent sample designs for case-control studies. , 1983, Journal of chronic diseases.

[26]  A. Dale,et al.  Regional and progressive thinning of the cortical ribbon in Huntington’s disease , 2002, Neurology.

[27]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[28]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[29]  André J. W. van der Kouwe,et al.  Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast , 2009, NeuroImage.

[30]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[31]  Aaron Carass,et al.  Longitudinal changes in cortical thickness associated with normal aging , 2010, NeuroImage.

[32]  D. Norris,et al.  Causes and consequences of cerebral small vessel disease. The RUN DMC study: a prospective cohort study. Study rationale and protocol , 2011, BMC neurology.

[33]  Bruce Fischl,et al.  Regional white matter volume differences in nondemented aging and Alzheimer's disease , 2009, NeuroImage.

[34]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[35]  C. Jack,et al.  Alzheimer's Disease Neuroimaging Initiative (ADNI) , 2010, Neurology.

[36]  Bram Stieltjes,et al.  Reduced Gray to White Matter Tissue Intensity Contrast in Schizophrenia , 2012, PloS one.

[37]  André J. W. van der Kouwe,et al.  Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease , 2011, NeuroImage.

[38]  A M Dale,et al.  Measuring the thickness of the human cerebral cortex from magnetic resonance images. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Mark E. Schmidt,et al.  The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans , 2010, Alzheimer's & Dementia.

[40]  W. Browner,et al.  Designing Clinical Research , 2006 .

[41]  S. Gauthier,et al.  Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment , 2012, PloS one.

[42]  R. Longo,et al.  Contrast between white and grey matter: MRI appearance with ageing , 1993, European Radiology.

[43]  H. Braak,et al.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.

[44]  Ronald C Petersen,et al.  Outcomes of mild cognitive impairment by definition: a population study. , 2011, Archives of neurology.